	US 12,290,542 B2
	Compositions comprising cannabis and mushroom extracts, and uses thereof
Parker Berling, San Francisco, CA (US); Tony M. Verzura, San Francisco, CA (US); and Kevin Hall, San Francisco, CA (US)
Assigned to Cookies Creative Consulting & Promotions, Inc., Downey, CA (US)
Filed by Cookies Creative Consulting & Promotions, Inc., Downey, CA (US)
Filed on Mar. 6, 2024, as Appl. No. 18/597,236.
Application 18/597,236 is a continuation of application No. 18/343,563, filed on Jun. 28, 2023, granted, now 11,951,142.
Application 18/343,563 is a continuation of application No. PCT/US2021/065708, filed on Dec. 30, 2021.
Claims priority of provisional application 63/132,878, filed on Dec. 31, 2020.
Prior Publication US 2024/0252569 A1, Aug. 1, 2024
Int. Cl. A61K 36/07 (2006.01); A61K 31/00 (2006.01); A61K 31/015 (2006.01); A61K 31/56 (2006.01); A61K 36/062 (2006.01)

CPC A61K 36/07 (2013.01) [A61K 31/015 (2013.01); A61K 31/56 (2013.01); A61K 31/658 (2023.05); A61K 36/062 (2013.01)]

19 Claims

1. A capsule comprising:

i. a Cannabinoid Fraction comprising purified cannabidiol (CBD) and purified cannabinol (CBN);

ii. a Mushroom Extract Fraction comprising Trametes versicolor, Ganoderma lingzhi, Grifola frondosa, Lentinula edodes, and Inonotus obliquus; and

iii. a Terpene Fraction.